Grécia - grego - Εθνικός Οργανισμός Φαρμάκων

statens serum institut, denmark (0000005700) artillerivej 5,, dk-2300 copenhagen s - poliovirus vaccine; poliovirus vaccine; poliovirus vaccine - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - 8000034777 poliovirus vaccine 40.000000 du; 8000034777 poliovirus vaccine 8.000000 du; 8000034777 poliovirus vaccine 32.000000 du - poliomyelitis, trivalent, inactivated, whole virus

Itália - italiano - Ministero della Salute

arysta lifescience benelux sprl - olio di paraffina/(cas 97862-82-3); - concentrato emulsionabile - 85.0 g i valori indicati sono per 100 g di prodotto. - insetticida

Israel - inglês - Ministry of Health

glaxo smith kline (israel) ltd - poliomyelitis virus type 1; poliomyelitis virus type 1; poliomyelitis virus type 3 - suspension - poliomyelitis virus type 3 nlt 10^6.0 ccid50; poliomyelitis virus type 1 nlt 10^5.8 ccid50; poliomyelitis virus type 1 nlt 10^6.0 ccid50 - poliomyelitis oral, monovalent live attenuated - active immunisation against poliomyelitis infection caused by types 1 and 3 poliomyelitis viruses at any age after receiving at least one dose of ipv.

Itália - italiano - Ministero della Salute

kollant s.r.l. - olio di paraffina/(cas 97862-82-3); - concentrato emulsionabile - 80.0 g i valori indicati sono per 100 g di prodotto. - insetticida - insetticida - esente da classificazione di pericolo

Itália - italiano - Ministero della Salute

bayer ag - gli acidi grassi c7-c18 c18 e insaturi, sali di potassio (cas 67701-09-1); - emulsione olio/acqua (ew) - 47.8 g i valori indicati sono per 100 g di prodotto. - sali; potassici; di; acidi; grassi; (c14; -; c29):; 47,8%; (479,8; g/l) - insetticida-acaricida

Estados Unidos - inglês - NLM (National Library of Medicine)

a-s medication solutions - poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - ipol vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus types 1, 2, and 3. (28) it is recommended that all infants (as young as 6 weeks of age), unimmunized children, and adolescents not previously immunized be vaccinated routinely against paralytic poliomyelitis. (29) following the eradication of poliomyelitis caused by wild poliovirus from the western hemisphere (including north and south america) (30), an ipv-only schedule was recommended to eliminate vapp. (7) all children should receive four doses of ipv at ages 2, 4, 6 to 18 months, and 4 to 6 years. opv is no longer available in the us and is not recommended for routine immunization. (7) previous clinical poliomyelitis (usually due to only a single poliovirus type) or incomplete immunization with opv are not contraindications to completing the primary series of immunization with ipol vaccine. children of all ages should have their immuni

Itália - italiano - Ministero della Salute

syngenta italia s.p.a. - olio di paraffina/(cas 8012-95-1); parathion; -

Itália - italiano - Ministero della Salute

syngenta italia s.p.a. - olio di paraffina/(cas 8012-95-1); - concentrato emulsionabile - 80.0 g i valori indicati sono per 100 g di prodotto.

Itália - italiano - Ministero della Salute

agrico s.r.l. - olio di paraffina/(cas 8012-95-1); - concentrato emulsionabile - 80.0 g i valori indicati sono per 100 g di prodotto.

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - polio virus type 1 inactivated, polio virus type 2 inactivated, polio virus type 3 inactivated - suspension for injection - %v/v - poliomyelitis vaccines